Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
62 participants
OBSERVATIONAL
2024-05-21
2025-12-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Will regions of known patellar tendon pathology present with smaller DTI scalar parameters, shorter fiber length, and lower fiber density compared to the contralateral tendon and healthy regions in the ipsilateral tendon.
Participants will:
* undergo MRI and ultrasound imaging
* perform knee function test
* complete questionnaires
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Acute Effects of an Isometric Loading Intervention on Lower Extremity Landing Biomechanics in Individuals With Patellar Tendinopathy
NCT03262181
MRI Review of ACLR With and Without Lateral Extra-articular Tenodesis
NCT04114708
Patellar Tendinopathy - The Effect of Load Magnitude in Exercise-based Treatment
NCT03096067
Comparisons of Mechanical Properties of Tendon Structures
NCT00451087
The Acute Effect of Isometric Versus Isotonic Resistance Exercise in Patients With Patellar Tendinopathy
NCT03528746
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bone-patellar tendon-bone (BPTB)
This group will have patellar injury confirmed through self-reported surgical history and evidence of ipsilateral BPTB graft harvest on ultrasound.
MRI
MRI using DTI technology
Ultrasound (US)
Standard US
Neuromuscular electric stimulation (NMES)
Standard NMES
Patellar tendinopathy group
This group will have patellar tendinopathy confirmed based on International Scientific Tendinopathy Symposium Consensus on Clinical Terminology (ICON) statement, which defines patellar tendinopathy as "persistent patellar tendon pain and loss of function related to mechanical loading." Ultrasound diagnosis must confirm alteration of tendon macrostructure.
MRI
MRI using DTI technology
Ultrasound (US)
Standard US
Neuromuscular electric stimulation (NMES)
Standard NMES
Healthy knees
Control group of participants with healthy knees
MRI
MRI using DTI technology
Ultrasound (US)
Standard US
Neuromuscular electric stimulation (NMES)
Standard NMES
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI
MRI using DTI technology
Ultrasound (US)
Standard US
Neuromuscular electric stimulation (NMES)
Standard NMES
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have patellar tendon injury as confirmed through subjective report, clinical examination, and ultrasound by an experienced physical therapist
* Patellar tendinopathy group must present with current symptoms of patellar tendinopathy
* Control group must have no history of patellar tendon injury
Exclusion Criteria
* Participants with history of contralateral BPTB autograft harvest, or ACLR using any other graft type
* Participants with contraindications to MRI
* Participants with contraindications to NMES
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bryan Heiderscheit, PT, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Daniel Cobian, DPT, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wisconsin - Madison
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A536130
Identifier Type: OTHER
Identifier Source: secondary_id
SMPH/ORTHO&REHAB/PHYS THER
Identifier Type: OTHER
Identifier Source: secondary_id
Protocol Version 10/1/2025
Identifier Type: OTHER
Identifier Source: secondary_id
2024-0057
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.